Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated with Pembrolizumab. (2024). SKIN The Journal of Cutaneous Medicine, 8(6), 2006-2010. https://doi.org/10.25251/skin.8.6.17